Weight Loss Medication News

This living topic explores the growing influence of weight loss medications, particularly GLP-1 receptor agonists, on obesity treatment and healthcare access. Key issues include the effectiveness of these drugs, the rising demand for both injectable and oral options, and the financial burden associated with monthly treatment costs, which can exceed $1,000. Articles examine the disparities in access to these medications, regional trends in usage, and the challenges posed by insurance coverage limitations. The topic also delves into concerns surrounding side effects, long-term efficacy, and the evolving landscape of prescription weight loss treatments.

Latest

GLP-1 microdoses not a good idea, doctors warn

Microdosing GLP-1 sounds good but scientists say it's not proven and could be harmful

Jan. 16, 2026 By James R. Hood

Consumers say that smaller doses of a popular weight-loss drug eased side effects and improved their health

Telehealth companies are increasingly marketing GLP-1 “microdosing” for longevity and wellness

Scientists say there’s little evidence that nonstandard doses are safe or effective

The anecdotes are everywhere —stories of consumers who switched from full doses of GLP-1 drugs to microdoses and saw outstanding results: more energy, fewer gastrointestinal effects and big f...

Read Article

2026